The diagnosis and treatment of autoimmune blistering skin diseases.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Deutsches Ärzteblatt International

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3238/arztebl.2011.0399PMID 21712975PMCID PMC3123771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.

  2010cited by this paper
• Clinical and immunopathological spectrum of paraneoplastic pemphigus

  2010cited by this paper
• Interventions for bullous pemphigoid.

  2010cited by this paper
• Immunoadsorption in dermatology

  2010cited by this paper
• Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients

  2010cited by this paper
• High-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune Skin Blistering Diseases

  2010cited by this paper
• A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.

  2009cited by this paper
• A randomized double-blind trial of intravenous immunoglobulin for pemphigus.

  2009cited by this paper
• Research in practice: diagnosis of subepidermal autoimmune bullous disorders

  2009cited by this paper
• Rituximab in Severe Pemphigus

  2009cited by this paper
• Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2‐year prospective study

  2009cited by this paper
• Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany

  2009cited by this paper
• The use of sulfasalazine and pentoxifylline (low‐cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study

  2009cited by this paper
• Anti-laminin gamma-1 pemphigoid

  2009cited by this paper
• Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.

  2009cited by this paper
• Current treatment of autoimmune blistering diseases.

  2009cited by this paper
• Interventions for pemphigus vulgaris and pemphigus foliaceus.

  2009cited by this paper
• B-cell-directed therapy for inflammatory skin diseases.

  2009cited by this paper
• Use of high‐dose immunoglobulins in dermatology

  2009cited by this paper
• Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet.

  2009cited by this paper
• Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid

  2009cited by this paper
• Schleimhautpemphigoid mit okulärer Beteiligung

  2008cited by this paper
• Improvement of intravenous immunoglobulin therapy for bullous pemphigoid by adding immunosuppressive agents: marked improvement in depletion of circulating autoantibodies.

  2008cited by this paper
• Schleimhautpemphigoid mit okulärer Beteiligung

  2008cited by this paper
• CD20-directed therapy in autoimmune diseases involving the skin: role of rituximab

  2008cited by this paper
• Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study

  2008cited by this paper
• Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases §

  2008cited by this paper
• Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.

  2008cited by this paper
• The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies.

  2007cited by this paper
• Safety of intravenous immunoglobulin (IVIG) therapy.

  2007cited by this paper
• Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins

  2007cited by this paper
• Enzyme‐linked immunosorbent assay using multimers of the 16th non‐collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies

  2007cited by this paper
• Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases

  2007cited by this paper
• Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.

  2007cited by this paper
• Rituximab in autoimmune bullous diseases: mixed responses and adverse effects

  2007cited by this paper
• Prolonged Clinical Remission of Patients with Severe Pemphigus upon Rapid Removal of Desmoglein-Reactive Autoantibodies by Immunoadsorption

  2006cited by this paper
• Induction of Complement-Fixing Autoantibodies against Type VII Collagen Results in Subepidermal Blistering in Mice1

  2006cited by this paper
• Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.

  2006cited by this paper
• A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.

  2006cited by this paper
• Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients

  2006cited by this paper
• Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients.

  2006cited by this paper
• Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.

  2006cited by this paper
• Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption

  2006cited by this paper
• Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity

  2006cited by this paper
• Interventions for bullous pemphigoid.

  2005cited by this paper
• Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.

  2005cited by this paper
• Pemphigus.

  2005cited by this paper
• Bullöse Autoimmundermatosen (II): Therapie

  2004cited by this paper
• [Blistering autoimmune dermatoses (II): therapy].

  2004cited by this paper
• Paraneoplastic pemphigus.

  2004cited by this paper
• Development of an ELISA for the detection of autoantibodies to BP230.

  2004cited by this paper
• Immunoblotting and Enzyme-Linked Immunosorbent Assay for the Diagnosis of Pemphigoid Gestationis

  2004cited by this paper
• Management of autoimmune bullous diseases: pharmacology and therapeutics.

  2004cited by this paper
• Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus

  2003cited by this paper
• Serum levels of autoantibodies to desmoglein 3 in patients with therapy-resistant pemphigus vulgaris successfully treated with adjuvant intravenous immunoglobulins.

  2003cited by this paper
• Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan‐linked polyvinylalcohol adsorber

  2003cited by this paper
• Guidelines for the management of pemphigus vulgaris

  2003cited by this paper
• A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.

  2002cited by this paper
• Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review.

  2002cited by this paper
• Epidermal Transglutaminase (TGase 3) Is the Autoantigen of Dermatitis Herpetiformis

  2002cited by this paper
• A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

  2002cited by this paper
• Increased incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans

  2002cited by this paper
• The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.

  2002cited by this paper
• Guidelines for the management of bullous pemphigoid

  2002cited by this paper
• Linear IgA disease: successful treatment with erythromycin

  2002cited by this paper
• Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra‐ and extracellular domains of bullous pemphigoid antigen 180

  2001cited by this paper
• The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels

  2001cited by this paper
• Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin.

  2001cited by this paper
• Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment.

  2001cited by this paper
• Anti-epiligrin cicatricial pemphigoid and relative risk for cancer.

  2001cited by this paper
• Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.

  2000cited by this paper
• Cicatricial pemphigoid.

  2000cited by this paper
• IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.

  2000cited by this paper
• Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases.

  2000cited by this paper
• Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris.

  2000cited by this paper
• Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.

  2000cited by this paper
• Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence.

  1999cited by this paper
• Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus

  1999cited by this paper
• The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.

  1999cited by this paper
• Antiepiligrin Cicatricial Pemphigoid An Underdiagnosed Entity Within the Spectrum of Scarring Autoimmune Subepidermal Bullous Diseases ?

  1999cited by this paper
• Immunpathologische Veränderungen bei 115 Patienten mit bullösem Pemphigoid

  1999cited by this paper
• [Immunopathologic changes in 115 patients with bullous pemphigoid].

  1999cited by this paper
• Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.

  1999cited by this paper
• Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (α3β3γ2)

  1998cited by this paper
• Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (alpha3beta3gamma2).

  1998cited by this paper
• Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.

  1998cited by this paper
• Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.

  1997cited by this paper
• Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.

  1997cited by this paper
• A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.

  1997cited by this paper
• LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells.

  1996cited by this paper
• A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.

  1996cited by this paper
• Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.

  1995cited by this paper
• Lichen planus pemphigoides: identification of 180 kd hemidesmosome antigen.

  1995cited by this paper
• Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany.

  1995cited by this paper
• Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions

  1995cited by this paper
• Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.

  1994cited by this paper
• Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.

  1993cited by this paper
• [Paraneoplastic pemphigus].

  1993cited by this paper
• A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

  1993cited by this paper
• Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia

  1991cited by this paper

• Adaptation and Validation of the Fear of Blistering Disease Recurrence Inventory.

  2025cites this paper
• Senear–Usher Syndrome or Coexistence of SLE with Pemphigus Vulgaris—A Case Report with Literature Review

  2025cites this paper
• Environmental triggers of pemphigus vulgaris and bullous pemphigoid: a case control study

  2024cites this paper
• Senear-Usher syndrome in a 5-year-old girl

  2024cites this paper
• Store-and-Forward Inpatient Teledermatology Improves Care for Hospitalized Patients with Bullous Eruptions After a Primary Inpatient Team Consultation: A Retrospective Study.

  2023cites this paper
• Oral Pemphigus Vulgaris: A Case Report With Review of Literature

  2023cites this paper
• Utility of IgG4 immunohistochemistry detection in pemphigus diagnosis

  2022cites this paper
• Scientific and Clinical Abstracts From WOCNext® 2022: Fort Worth, Texas ♦ June 5-8, 2022.

  2022cites this paper
• Current approaches to the diagnosis of autoimmune bullous dermatoses

  2021cites this paper
• Deep Learning-Aided Diagnosis of Autoimmune Blistering Diseases

  2021cites this paper
• Pathogenic autoantibody derived from Treg-deficient scurfy mice targets Col7 and leads to Epidermolysis bullosa acquisita-like blistering disease.

  2021cites this paper
• Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine

  2021cites this paper
• Identification and evaluation of fructose-bisphosphate aldolase B as a potential diagnostic biomarker in choledochal cysts patients: a quantitative proteomic analysis

  2021cites this paper
• Anti-P 200 pemphigoid - The most common floor binding subepidermal autoimmune bullous disease in a tertiary care center in south India.

  2021cites this paper
• ELISA Detection of Anti-Desmoglein 1 and 3 and Indirect Immunofluorescence in Oral Pemphigus: a retrospective study.

  2021cites this paper
• Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid

  2021influential citation
• Klinik für Dermatologie, Allergologie und Venerologie der Universität zu Lübeck: Interaktion von Forschung und klinischer Versorgung

  2020cites this paper
• Propranolol is an effective topical and systemic treatment option for experimental epidermolysis bullosa acquisita.

  2020cites this paper
• Treatment options for autoimmune bullous dermatoses other than systemic steroids: A systematic review and network meta‐analysis

  2020cites this paper
• Hornhautveränderungen bei Liderkrankungen

  2020cites this paper
• [Corneal alterations in eyelid diseases].

  2020cites this paper
• Geriatric Vulvar Dermatology

  2020cites this paper
• Atypical Wounds

  2019cites this paper
• Rosettenartige Blasenbildung bei einem Mädchen

  2019cites this paper
• A comparative study of Michel's medium versus honey as a transport medium for skin specimens prior to direct immunofluorescence microscopy and antigen mapping

  2019cites this paper
• Bullöse Autoimmundermatosen im Kindesalter

  2019cites this paper
• Epidermolysis bullosa acquisita

  2019cites this paper
• [Linear IgA bullous dermatosis].

  2019cites this paper
• Aktuelle Therapie des Pemphigus

  2019cites this paper
• Bullous pemphigoid triggered by rabies vaccine

  2019cites this paper
• Resolution in bullous pemphigoid

  2019cites this paper
• Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases

  2019cites this paper
• Serological Diagnosis of Autoimmune Bullous Skin Diseases

  2019cites this paper
• Bullöse Autoimmundermatosen

  2019cites this paper
• Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management

  2018cites this paper
• Anti‐laminin 332 mucous membrane pemphigoid with laryngeal involvement – adjuvant treatment with immunoadsorption and rituximab

  2018cites this paper
• Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice

  2018cites this paper
• Adjuvante Behandlung des schweren/refraktären bullösen Pemphigoids mit Protein‐A‐Immunadsorption

  2018cites this paper
• Adjuvant treatment of severe/refractory bullous pemphigoid with protein A immunoadsorption

  2018cites this paper
• 85/m mit Blasen am gesamten Integument

  2018cites this paper
• Diagnosis of Autoimmune Blistering Diseases

  2018cites this paper
• Chapter 8 Current Therapy in Autoimmune Bullous Diseases

  2018cites this paper
• Immunadsorption in der Dermatologie

  2018cites this paper
• Wound Care in Immunobullous Disease

  2018cites this paper
• Lineare IgA-Dermatose − interessanter Fall einer seltenen Erkrankung

  2018cites this paper
• Linear IgA dermatosis in a 7 year old child

  2018cites this paper
• Subepidermal blistering disorders (SBD) are diseases associated with antibodies that attack structural proteins of the skin. Blister formation with widespread distribution is common in these diseases. The diagnosis of SBD is established through demonstration of immunoglobulin deposits in the dermoep

  2018cites this paper
• Schleimhautpemphigoid

  2017cites this paper
• Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid

  2017cites this paper
• Blistering diseases in the mature patient.

  2017cites this paper
• Non‐bullous lesions as the first manifestation of bullous pemphigoid: A retrospective analysis of 181 cases

  2017cites this paper
• Advanced Diagnostic Techniques in Autoimmune Bullous Diseases

  2017cites this paper
• Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin

  2017cites this paper
• Neurological and psychiatric associations in bullous pemphigoid—more than skin deep?

  2017cites this paper
• Alte Dame mit Blasen auf der Haut

  2017cites this paper
• Current Therapy in Autoimmune Bullous Diseases

  2017cites this paper
• Esophageal Manifestations of Bullous Pemphigoid

  2017influential citation
• Differential diagnostics of bullous dermatoses

  2016cites this paper
• Dermatology Eponyms – sign – Lexicon (T). Part 1

  2016cites this paper
• IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases

  2016cites this paper
• Bullous Pemphigoid with Lymphocytic Colitis: A Case Report and Short Literature Review

  2016cites this paper
• Automated direct immunofluorescence analyses of skin biopsies

  2016cites this paper
• Sera and salivary matrix metalloproteinases are elevated in patients with vesiculoerosive disease: a pilot study.

  2016cites this paper
• alternate day corticosteroid therapy in pemphigus vulgaris and bullous pemphigoid

  2016cites this paper
• Dermatosis ampollosas de la infancia

  2015cites this paper
• Quality of life index in autoimmune bullous dermatosis patients*

  2015cites this paper
• S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid

  2015cites this paper
• Skin Biopsy, the Allergists’ Tool: How to Interpret a Report

  2015cites this paper
• Blistering Diseases – Pemphigoid

  2015cites this paper
• Autoantibody Levels and Clinical Disease Severity in Patients with Pemphigus: Comparison of Aggregated Anti-desmoglein ELISA Values and Indirect Immunofluorescence Titres.

  2015cites this paper
• S2k‐Leitlinie zur Diagnostik des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids

  2015cites this paper
• Dresdner Dermatologische Demonstration 2015 – zugleich Tagung der Sächsischen Dermatologischen Gesellschaft am 21. März 2015

  2015cites this paper
• Life‐threatening course of pemphigus vulgaris complicated by sepsis caused by azathioprine‐induced bone marrow suppression, successfully managed with combination therapy

  2014cites this paper
• Scabies Manifesting as Bullous Pemphigus in a Nursing Home Resident

  2014cites this paper
• Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins

  2014cites this paper
• Evidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis

  2014cites this paper
• Current methods of treatment of true acantholytic pemphigus

  2014cites this paper
• Bullöse Autoimmunkrankheiten bei Kindern

  2014cites this paper
• Dermatoses bulleuses de l’enfant

  2014cites this paper
• A Rare Case of Vagal Syncope

  2014cites this paper
• [Autoimmune blistering skin diseases: diagnostic and therapeutic approach].

  2014cites this paper
• Role of polymorphisms of PERP gene in the development of acantholysis in patients with pemphigus vulgaris

  2013cites this paper
• Role of the clinical immunology laboratory in disease monitoring

  2013cites this paper
• [Bullous autoimmune disorders in children].

  2013cites this paper
• Neue diagnostische und therapeutische Methoden

  2013cites this paper
• Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases

  2013cites this paper
• Pênfigo vulgar em homem jovem: relato de caso e revisão da literatura

  2013cites this paper
• Beware the blistering patient with dysphonia

  2013cites this paper
• Concomitant Bullous Pemphigoid and Dermatitis Herpetiformis

  2013cites this paper
• Biologics in oral medicine: ulcerative disorders.

  2013cites this paper
• Antigen identification using skin deficient in basement‐membrane protein: a novel tool for the diagnosis of subepidermal immunobullous diseases

  2013cites this paper
• Bullöse Autoimmunkrankheiten bei Kindern

  2013cites this paper
• Bullöses Pemphigoid

  2013cites this paper
• Refractory mucous membrane pemphigoid which developed after allogeneic stem cell transplantation and was successfully treated with rituximab.

  2013cites this paper
• Pemphigus vulgaris

  2013cites this paper
• Pemphigus erythematosus mit Übergang in einen Pemphigus foliaceus

  2012cites this paper
• Antibodies to the C-terminus of laminin γ1 are present in a distinct subgroup of patients with systemic and cutaneous lupus erythematosus

  2012cites this paper
• Diagnosis and treatment of pemphigus.

  2012cites this paper
• Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy

  2012cites this paper
• Development of Specific Immunoadsorbers for the Treatment of Human Pemphigus Diseases

  2012cites this paper